Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery

Human Reproduction

Volumn 22, Issue 4, 2007, Pages 1003-1010

  Seow, Kok Min ^a,b   Juan, Chi Chang ^b,c   Hsu, Yung Pei ^c   Hwang, Jiann Loung ^a,d,e   Huang, Lee Wen ^a,d,e   Ho, Low Tone ^b,c  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Extracellular signal regulated kinase; Laparoscopic ovarian electrocautery; Phosphatidylinositol 3 kinase; Serine phosphorylation

Indexed keywords

CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR SUBSTRATE 1; LUTEINIZING HORMONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE; SERINE; TESTOSTERONE; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; PHOSPHOPROTEIN; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; AMENORRHEA; ARTICLE; BLOOD SAMPLING; CAUTERIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LAPAROSCOPY; MITOGENESIS; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; BODY MASS; CHEMISTRY; ELECTROCOAGULATION; GLUCOSE TOLERANCE TEST; METABOLISM; METHODOLOGY; OVARY; PATHOLOGY; PHOSPHORYLATION; RISK; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BODY MASS INDEX; ELECTROCOAGULATION; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LAPAROSCOPY; OVARY; PHOSPHOPROTEINS; PHOSPHORYLATION; POLYCYSTIC OVARY SYNDROME; RISK; SERINE; SIGNAL TRANSDUCTION;

EID: 34347233825     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del466     Document Type: Article

References (36)

1. Amer SAK, Banu Z, Li TC and Cooke ID (2002) Long-termfollow-up of patients with polycystic ovary syndrome after laparoscopic ovarian drilling: endocrine and ultrasonographic outcomes. Hum Reprod 11,2851-2857.
2. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S and Escobar-Morreale HF (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85,2434-2438.
3. Balen AH, Laven JS, Tan SL and Dewailly D (2003) Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9,505-514.
4. Campo S, Felli A, Lamanna MA, Barini A and Garcea N (1993) Endocrine changes and clinical outcome after laparoscopic ovarian resection in women with polycystic ovaries. Hum Reprod 8,359-363.
5. Ciaraldi TP, el-Roeiy A, Madar Z, Reichart D, Olefsky JM and Yen SS (1992) Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab 75,577-583.
6. Corbould A, Kim Y-B, Youngren JF, Pender C, Kahn BB, Lee A and Dunaif A (2005) Insulin resistance in the skeletal muscle of women with polycystic ovary syndrome involves both intrinsic and acquired defects in insulin signaling. Am J Physiol Endocrinol Metab 288,1047-1054.
7. Corbould A, Zhao H, Mirzoeva S, Aird F and Dunaif A (2006) Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome. Diabetes 55,751-759.
8. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED and Bartzis MZ (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84,4006-4011.
9. Dong C, Waters SB, Holt KH and Pessin JE (1996) SOS phosphorylation and disassociation of the Grb2-SOS complex by the ERK and JNK signaling pathways. J Biol Chem 271,6382-6332.
10. Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18,774-800.
11. Dunaif A, Green G, Phelps RG, Lebwohl M, Futterweit W and Lewy L (1991) Acanthosis nigricans, insulin action and hyperandrogenism: clinical, histological and biochemical findings. J Clin Endocrinol Metab 73,590-595.
12. Dunaif A, Xia J, Book CB, Schenker E and Tang Z (1995) Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle: a potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 96,801-810.
13. Dunaif A, Wu X, Lee A and Diamanti-Kandarakis E (2001) Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab 281,E392-E399.
14. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK and Imperial J (1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22,141-146.
15. Franks S (1995) Polycystic ovary syndrome. N Engl J Med 333,853-861.
16. Gjonnaess H (1998) Late endocrine effects of ovarian electrocautery in women with polycystic ovary syndrome. Fertil Steril 69,697-701.
17. Goke B (1998) Implications of blood glucose, insulin resistance and beta-cell function in impaired glucose tolerance. Diabetes Res Clin Pract 40,S15-S20.
18. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ and Dohm GL (1995) Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95,2195-2204.
19. Goodyear LJ, Chang PY, Sherwood DJ, Dufresne SD and Moller DE (1996) Effects of exercise and insulin on mitogen-activated protein kinase signaling pathways in rat skeletal muscle. Am J PHysiol 271,E403-E408.
20. Kauffman RP, Baker VM, Dimarino P, Gimpel T and Castracane VD (2002) Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. Am J Obstet Gynecol 187,1362-1369.
21. Legro RS, Finegood D and Dunaif A (1998) A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83,2694-2698.
22. Legro RS, Kunselman AR, Dodson WC and Dunaif A (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84,165-169.
23. Lemieux S, Lewis GF, Ben-Chetrit A, Steiner G and Greenblatt EM (1999) Correction of hyperandrogenemia by laparoscopic ovarian cautery in women with polycystic ovarian syndrome is not accompanied by improved insulin sensitivity or lipid-lipoprotein levels. J Clin Endocrinol Metab 84,4278-4282.
24. Li TC, Saravelos H, Chow MS, Chisabingo R and Cooke ID (1998) Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovary syndrome in women with anovulatory infertility. Br J Obstet Gynecol 105,338-344.
25. Li M, Youngren JF, Duanif A, Goldfine ID, Maddux BA, Zhang BB and Evans JL (2002) Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators. J Clin Endocrinol Metab 87,4088-4093.
26. Lobo RA, Gysler M, March CM, Goebelsmann U and Mishell DR (1982) Clinical and laboratory predictors of clomiphene response. Fertil Stril 37,168-174.
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF and Turner RC (1985) Homeostasis model assessment: insulin resistance and [beta]-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28,412-419.
28. Moxham CM, Tabrizchi A, Davis RJ and Malbon CC (1996) Jun N-terminal kinase mediates activation of skeletal muscle glycogen synthase by insulin in vivo. J Biol Chem 271, 30765-30773.
29. Naether OGJ, Baukloh V, Fischer R and Kowalczyk T (1994) Long-term follow-up in 206 infertility patients with polycystic ovary syndrome after laparoscopic electrocautery of the ovarian surface. Hum Reprod 9,2342-2349.
30. Nestler JE, Jakubowicz DJ, Evans WS and Pasquali R (1998) Effective metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 338,1876-1880.
31. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group(2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19,41-47.
32. Seow KM, Juan CC, Wu LY, Hsu YP, Yang WM, Tsai YL, Hwang JL and Ho LW (2004) Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance. Hum Reprod 1,48-53.
33. Shimanuki T, Nishimura K, Montz FJ, Nakamura RM and diZerega GS (1987) Localized prevention of postsurgical adhesion formation and reformation with oxidized regenerated cellulose. J Biomed Mater Res 21,173-185.
34. Stein IF and Leventhal ML (1935) Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29,181-191.
35. Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW and Nestler JE (2001) Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril 75,310-315.
36. Virkamaki A, Ueki K and Kahn CR 1999 Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance J Clin Invest 103,931-943.